Krishna Vaddi
2020
In 2020, Krishna Vaddi earned a total compensation of $11.6M as Chief Executive Officer at Prelude Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $228,667 |
|---|---|
| Option Awards | $9,576,741 |
| Salary | $417,058 |
| Stock Awards | $1,409,998 |
| Total | $11,632,464 |
Vaddi received $9.6M in option awards, accounting for 82% of the total pay in 2020.
Vaddi also received $228.7K in non-equity incentive plan, $417.1K in salary and $1.4M in stock awards.
Rankings
In 2020, Krishna Vaddi's compensation ranked 656th out of 13,090 executives tracked by ExecPay. In other words, Vaddi earned more than 95.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 656 out of 13,090 | 95th |
Division Manufacturing | 228 out of 5,624 | 96th |
Major group Chemicals And Allied Products | 73 out of 2,257 | 97th |
Industry group Drugs | 62 out of 1,957 | 97th |
Industry Pharmaceutical Preparations | 46 out of 1,462 | 97th |
Source: SEC filing on April 29, 2022.
Vaddi's colleagues
We found three more compensation records of executives who worked with Krishna Vaddi at Prelude Therapeutics in 2020.